Andrew Just
Independent Non-Executive Director

Graduating from Macquarie University with a Bachelor of Economics (Economics & Business Law) and Monash University with a Bachelor’s degree in health economics, Andrew Just was employed by Roche Pharmaceuticals as a Health Economist.

He built economic models for inclusion of Roche products on the Australian Medical Benefits Scheme and then in GE Healthcare where he ultimately was appointed General Manager of Services for Australia and New Zealand leading a team of 152 staff.

He gained his MBA from the University of New South Wales and has since gained over 25 years of highly relevant global senior executive experience in the healthcare industry at Fortune 500 and ASX listed companies including Stryker, Cochlear, GE Healthcare, Radiometer, Roche, and Novartis.

Andrew has prior ASX experience having previously been the Chief Executive Officer and Managing Director of ASX listed company Paragon Care Limited (ASX:PGC) and strong governance experience from previous roles and as a Graduate of the Australian Institute of Company Directors.

Subscribe for the latest company news and announcements

Board of Directors

Howard Digby

Non-Executive Chairman

Holding a Bachelor of Engineering (Hons) from the University of Western Australia, Howard Digby began his career at IBM and has spent over 25 years managing technology-related businesses in the Asia Pacific region, of which 11 years were spent in Hong Kong.

Currently a Non-Executive Director of 4DS Memory (ASX:4DS), Elsight (ASX:ELS), Cirralto (ASX:CRO), and previously a Non-Executive Director of ImeHXS (ASX:IME), Howard has strong ASX and corporate governance experience with technology and digital health companies.

Thomas Hanly

Managing Director and Chief Executive Officer

Holding a Bachelor of Commerce (Resource and Environmental Economics), Thomas’ early career saw him work as an economic analyst for AgricultureNZ before moving to the United States where he obtained his Series 7 and was employed in private banking with Merrill Lynch.

With a strong understanding of capital markets and an interest in technology, Thomas was heavily involved in the early 2000’s driving the development and commercialisation of a financial services start-up in the United States before returning to Australia and working in R&D consulting prior to Singular Health.

Guan Tay PhD

Executive Director of Innovation

Having attained his PhD from the Centre for Molecular Immunology and Instrumentation at the University of Western Australia, an MBA and a Bachelor of Science from Murdoch University, Dr Guan Tay is highly respected in the medical & educational sectors and has held various academic positions in Australia and the United Arab Emirates.

Andrew Just

Non-Executive Director

With Bachelor’s degrees in Economics & Health Economics from Macquarie University and Monash University and an MBA from UNSW, Andrew Just has held senior management roles in multiple Tier 1 health companies.

Andrew has prior ASX experience having been the CEO and MD of Paragon Care Ltd. (ASX:PGC).

Denning Chong

Non-Executive Director

Denning Chong has been the principal of James Chong Lawyers since 2004 and holds multiple directorships in property & investment companies.

Denning is one of the founders of Singular Health and has been involved in the early stage funding and governance of Singular Health since its incorporation.